The NHS Health Check in England: an evaluation of the first 4 years
- John Robson1,
- Isabel Dostal1,
- Aziz Sheikh2,
- Sandra Eldridge1,
- Vichithranie Madurasinghe1,
- Chris Griffiths1,
- Carol Coupland3,
- Julia Hippisley-Cox3
- 1Centre for Primary Care and Public Health, Queen Mary University of London, London, UK
- 2Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh, Edinburgh, UK
- 3School of Community Health Sciences, The University of Nottingham, Nottingham, UK
- Correspondence to John Robson;
- Received 20 May 2015
- Revised 1 September 2015
- Accepted 28 September 2015
- Published 13 January 2016
Objectives To describe implementation of a new national preventive programme to reduce cardiovascular morbidity.
Design Observational study over 4 years (April 2009—March 2013).
Setting 655 general practices across England from the QResearch database.
Participants Eligible adults aged 40–74 years including attendees at a National Health Service (NHS) Health Check.
Intervention NHS Health Check: routine structured cardiovascular check with support for behavioural change and in those at highest risk, treatment of risk factors and newly identified comorbidity.
Results Of 1.68 million people eligible for an NHS Health Check, 214 295 attended in the period 2009–12. Attendance quadrupled as the programme progressed; 5.8% in 2010 to 30.1% in 2012. Attendance was relatively higher among older people, of whom 19.6% of those eligible at age 60–74 years attended and 9.0% at age 40–59 years. Attendance by population groups at higher cardiovascular disease (CVD) risk, such as the more socially disadvantaged 14.9%, was higher than that of the more affluent 12.3%. Among attendees 7844 new cases of hypertension (38/1000 Checks), 1934 new cases of type 2 diabetes (9/1000 Checks) and 807 new cases of chronic kidney disease (4/1000 Checks) were identified. Of the 27 624 people found to be at high CVD risk (20% or more 10-year risk) when attending an NHS Health Check, 19.3% (5325) were newly prescribed statins and 8.8% (2438) were newly prescribed antihypertensive therapy.
Conclusions NHS Health Check coverage was lower than expected but showed year-on-year improvement. Newly identified comorbidities were an important feature of the NHS Health Checks. Statin treatment at national scale for 1 in 5 attendees at highest CVD risk is likely to have contributed to important reductions in their CVD events.
This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/